326 related articles for article (PubMed ID: 30741923)
21. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D
Front Immunol; 2020; 11():576651. PubMed ID: 33042160
[TBL] [Abstract][Full Text] [Related]
23. 1,25(OH)
Sun D; Luo F; Xing JC; Zhang F; Xu JZ; Zhang ZH
Cell Prolif; 2018 Oct; 51(5):e12461. PubMed ID: 29687949
[TBL] [Abstract][Full Text] [Related]
24. E3 Ubiquitin Ligase Von Hippel-Lindau Protein Promotes Th17 Differentiation.
Chitrakar A; Budda SA; Henderson JG; Axtell RC; Zenewicz LA
J Immunol; 2020 Aug; 205(4):1009-1023. PubMed ID: 32690659
[TBL] [Abstract][Full Text] [Related]
25. Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis.
Zhang Z; Zhang K; Zhang M; Zhang X; Zhang R
Front Immunol; 2022; 13():856694. PubMed ID: 35514960
[TBL] [Abstract][Full Text] [Related]
26. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
27. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.
Zhu E; Wang X; Zheng B; Wang Q; Hao J; Chen S; Zhao Q; Zhao L; Wu Z; Yin Z
J Immunol; 2014 Jun; 192(12):5599-609. PubMed ID: 24842756
[TBL] [Abstract][Full Text] [Related]
28. Involvement of lncRNA-1700040D17Rik in Th17 cell differentiation and the pathogenesis of EAE.
Guo W; Lei W; Yu D; Ge Y; Chen Y; Xue W; Li Q; Li S; Gao X; Yao W
Int Immunopharmacol; 2017 Jun; 47():141-149. PubMed ID: 28395256
[TBL] [Abstract][Full Text] [Related]
29. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
Lee J; Choi J; Lee W; Ko K; Kim S
Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
[TBL] [Abstract][Full Text] [Related]
30. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
[TBL] [Abstract][Full Text] [Related]
31. Expression of Th17-related genes in PHA/IL-2-activated human T cells by Fas signaling via caspase-1- and Stat3-dependent pathway.
Su CC; Lin HC; Lin YP; Shan YS; Yang BC
Cell Immunol; 2013 Feb; 281(2):101-10. PubMed ID: 23590971
[TBL] [Abstract][Full Text] [Related]
32. PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5.
Sen S; He Z; Ghosh S; Dery KJ; Yang L; Zhang J; Sun Z
J Immunol; 2018 Jul; 201(2):440-450. PubMed ID: 29794014
[TBL] [Abstract][Full Text] [Related]
33. T cell-specific BLIMP-1 deficiency exacerbates experimental autoimmune encephalomyelitis in nonobese diabetic mice by increasing Th1 and Th17 cells.
Lin MH; Yeh LT; Chen SJ; Chiou HY; Chu CC; Yen LB; Lin KI; Chang DM; Sytwu HK
Clin Immunol; 2014 Apr; 151(2):101-13. PubMed ID: 24568746
[TBL] [Abstract][Full Text] [Related]
34. PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3.
Tanaka T; Yamamoto Y; Muromoto R; Ikeda O; Sekine Y; Grusby MJ; Kaisho T; Matsuda T
Sci Signal; 2011 Dec; 4(202):ra85. PubMed ID: 22155789
[TBL] [Abstract][Full Text] [Related]
35. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
36. Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis.
Piao CH; Song CH; Lee EJ; Chai OH
Chem Biol Interact; 2020 Jan; 315():108874. PubMed ID: 31669322
[TBL] [Abstract][Full Text] [Related]
37. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
[TBL] [Abstract][Full Text] [Related]
38. T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation.
Molinero LL; Cubre A; Mora-Solano C; Wang Y; Alegre ML
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18529-34. PubMed ID: 23091043
[TBL] [Abstract][Full Text] [Related]
39. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
40. STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance.
Gharibi T; Barpour N; Hosseini A; Mohammadzadeh A; Marofi F; Ebrahimi-Kalan A; Nejati-Koshki K; Abdollahpour-Alitappeh M; Safaei S; Baghbani E; Baradaran B
Int Immunopharmacol; 2023 Jun; 119():110160. PubMed ID: 37080068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
